Edition:
United States

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

22.90USD
3:59pm EST
Change (% chg)

$0.29 (+1.28%)
Prev Close
$22.61
Open
$22.61
Day's High
$22.96
Day's Low
$21.87
Volume
276,489
Avg. Vol
215,956
52-wk High
$41.75
52-wk Low
$21.38

Select another date:

Wed, Nov 28 2018

BRIEF-Aimmune Therapeutics Announces Closing Of $98 Mln Investment By Nestlé Health Science

* AIMMUNE THERAPEUTICS ANNOUNCES CLOSING OF $98 MILLION INVESTMENT BY NESTLÉ HEALTH SCIENCE

Nestle raises stake in food allergy drug developer Aimmune

The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to submit a marketing application for its peanut allergy drug by the end of the year.

UPDATE 2-Nestle raises stake in food allergy drug developer Aimmune

Nov 12 The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to submit a marketing application for its peanut allergy drug by the end of the year.

BRIEF-Aimmune Therapeutics Announces Additional Equity Investment By Nestlé Health Science

* AIMMUNE THERAPEUTICS ANNOUNCES ADDITIONAL EQUITY INVESTMENT BY NESTLÉ HEALTH SCIENCE

Nestle raises stake in food allergy drug developer Aimmune

Nov 12 The health science unit of Nestle SA would pay $98 million to increase its stake in Aimmune Therapeutics Inc, the drug developer for food allergies said on Monday.

Select another date: